EDITAS MEDICINE INC's ticker is EDIT and the CUSIP is 28106W103. A total of 310 filers reported holding EDITAS MEDICINE INC in Q1 2021. The put-call ratio across all filers is 0.67 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $113,553 | -7.8% | 14,558 | -2.7% | 0.00% | 0.0% |
| Q2 2023 | $123,179 | +16.6% | 14,967 | +2.7% | 0.00% | 0.0% |
| Q1 2023 | $105,633 | -6.3% | 14,570 | +14.7% | 0.00% | 0.0% |
| Q4 2022 | $112,685 | -44.5% | 12,704 | -23.5% | 0.00% | -50.0% |
| Q3 2022 | $203,000 | +0.5% | 16,615 | -2.6% | 0.01% | +14.3% |
| Q2 2022 | $202,000 | -28.6% | 17,059 | +14.7% | 0.01% | -12.5% |
| Q1 2022 | $283,000 | -6.3% | 14,872 | +30.6% | 0.01% | 0.0% |
| Q4 2021 | $302,000 | -33.2% | 11,388 | +3.5% | 0.01% | -42.9% |
| Q3 2021 | $452,000 | +13.0% | 11,005 | +55.9% | 0.01% | +16.7% |
| Q2 2021 | $400,000 | +41.3% | 7,061 | +74.9% | 0.01% | +20.0% |
| Q4 2020 | $283,000 | +21.5% | 4,038 | -37.9% | 0.01% | -37.5% |
| Q2 2018 | $233,000 | +7.4% | 6,507 | -0.7% | 0.02% | 0.0% |
| Q1 2018 | $217,000 | – | 6,550 | – | 0.02% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Flagship Pioneering Inc. | 1,674,435 | $51,455,000 | 13.05% |
| TRV GP III, LLC | 906,176 | $27,847,000 | 9.75% |
| ARK Investment Management | 1,112,845 | $34,198,000 | 2.72% |
| DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) | 1,709,400 | $52,530,000 | 2.07% |
| Casdin Capital, LLC | 133,333 | $4,097,000 | 1.00% |
| Global Thematic Partners, LLC | 614,052 | $18,869,000 | 0.62% |
| MORGENS WATERFALL VINTIADIS & CO INC | 20,000 | $615,000 | 0.48% |
| Ghost Tree Capital, LLC | 65,000 | $1,997,000 | 0.47% |
| ACUTA CAPITAL PARTNERS, LLC | 64,000 | $1,967,000 | 0.37% |
| VIKING GLOBAL INVESTORS LP | 1,709,401 | $52,530,000 | 0.32% |